Seeger Weiss Partner Shauna Itri Writes on COVID-19 Whistleblower Cases in Reuters

Seeger Weiss partner Shauna Itri was featured in Reuters, authoring a piece on how whistleblower claims can stop COVID-19 fraud. In the piece, “Using the False Claims Act to Combat COVID-19 Fraud,” Itri wrote: “Even though the pandemic began more than two years ago, it is likely that the widely predicted increase in qui tam-related […]

April 6, 2022

Seeger Weiss partner Shauna Itri was featured in Reuters, authoring a piece on how whistleblower claims can stop COVID-19 fraud. In the piece, “Using the False Claims Act to Combat COVID-19 Fraud,” Itri wrote:

“Even though the pandemic began more than two years ago, it is likely that the widely predicted increase in qui tam-related recoveries stemming from COVID-19 fraud will only begin to be seen this year. Fraudulent schemes take time to develop, be uncovered, and investigated either by the government or private counsel retained by the relator. Moreover, qui tam actions are filed in camera and under seal for 60 days, and the government may further request that a court extend the seal during any investigation into the matter. Nonetheless, we can look to existing enforcement actions to see what types of COVID-19 fraud whistleblowers will likely uncover.”

Shauna Itri has extensive experience representing relators in False Claims Act lawsuits as well as tax and securities whistleblowers with claims under the IRS and SEC whistleblower programs.

The full article can be found here.

Related News

March 12, 2026
Seeger Weiss Partner Parvin Aminolroaya and Counsel Max Kelly Appointed to Leadership Roles in GLP-1 NAION Products Liability Litigation

Seeger Weiss is proud to announce that Partner Parvin Aminolroaya has been appointed Co-Lead Counsel for Plaintiffs in the In Re: GLP-1 RAS Non-arteritic Anterior Ischemic Optic Neuropathy Products Liability Litigation and Counsel Max Kelly has been appointed to the Plaintiffs’ Executive Committee. The litigation involves claims that GLP-1 receptor agonist drugs including Ozempic, Wegovy, […]

Read More
February 18, 2026
Twelve Seeger Weiss Attorneys Named to The 2026 Lawdragon 500 Leading Plaintiff Consumer Lawyers Guide

Seeger Weiss is proud to announce that twelve Seeger Weiss attorneys have been selected for inclusion in the 2026 Lawdragon 500 Leading Plaintiff Consumer Lawyers guide. Congratulations to Christopher Seeger, Stephen Weiss, Parvin K. Aminolroaya, Ben Barnett, David R. Buchanan, Steven Daroci, Scott Alan George, Shauna Itri, Diogenes P. Kekatos, Michael L. Rosenberg, Jennifer Scullion, […]

Read More
February 17, 2026
$7.25 Billion Nationwide Roundup / Glyphosate Class Action Settlement To Provide Compensation To Those Diagnosed With Non-Hodgkin Lymphoma After Exposure To Weedkiller

ST. LOUIS, MO – A proposed nationwide class-action settlement resolving claims that exposure to Roundup herbicides caused non-Hodgkin lymphoma (NHL) was filed today in the 22nd Judicial Circuit Court for the City of St. Louis, Missouri. The settlement would make up to $7.25 billion available to compensate individuals across the United States who were exposed […]

Read More